These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1247972)

  • 41. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines.
    Haas JS; Sprague BL; Klabunde CN; Tosteson AN; Chen JS; Bitton A; Beaber EF; Onega T; Kim JJ; MacLean CD; Harris K; Yamartino P; Howe K; Pearson L; Feldman S; Brawarsky P; Schapira MM;
    J Gen Intern Med; 2016 Jan; 31(1):52-9. PubMed ID: 26129780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined fine-needle aspiration, physical examination and mammography in the diagnosis of palpable breast masses: their relation to outcome for women with primary breast cancer.
    Steinberg JL; Trudeau ME; Ryder DE; Fishell E; Chapman JA; McCready DR; Fish EB; Hiraki GY; Ross TM; Lickley LA
    Can J Surg; 1996 Aug; 39(4):302-11. PubMed ID: 8697321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey.
    Watson M; Benard V; King J; Crawford A; Saraiya M
    Prev Med; 2017 Jul; 100():243-247. PubMed ID: 28502575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Strategies for providing follow-up and treatment services in the National Breast and Cervical Cancer Early Detection Program--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Mar; 47(11):215-8. PubMed ID: 9551882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Linking laboratory and clinical research: the development of molecularly targeted therapeutics inside the national cancer institute center for cancer research.
    Barrett JC; Bennett LM; Fleming LK; Linehan WM; Liotta LA; Rosenberg SA; Petricoin EF; Staudt LM; Thompson TE; Yang JC
    Clin Adv Hematol Oncol; 2003 May; 1(5):302-6. PubMed ID: 16224427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Independent prognostic value of screen detection in invasive breast cancer.
    Mook S; Van 't Veer LJ; Rutgers EJ; Ravdin PM; van de Velde AO; van Leeuwen FE; Visser O; Schmidt MK
    J Natl Cancer Inst; 2011 Apr; 103(7):585-97. PubMed ID: 21350218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Level of awareness of cervical and breast cancer risk factors and safe practices among college teachers of different states in india: do awareness programmes have an impact on adoption of safe practices?
    Shankar A; Rath G; Roy S; Malik A; Bhandari R; Kishor K; Barnwal K; Upadyaya S; Srivastava V; Singh R
    Asian Pac J Cancer Prev; 2015; 16(3):927-32. PubMed ID: 25735384
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent trends in U.S. breast cancer incidence, survival, and mortality rates.
    Chu KC; Tarone RE; Kessler LG; Ries LA; Hankey BF; Miller BA; Edwards BK
    J Natl Cancer Inst; 1996 Nov; 88(21):1571-9. PubMed ID: 8901855
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The National Cancer Institute and guideline development: lessons from the breast cancer screening controversy.
    Kaluzny AD; Rimer B; Harris R
    J Natl Cancer Inst; 1994 Jun; 86(12):901-3. PubMed ID: 8196079
    [No Abstract]   [Full Text] [Related]  

  • 53. Hispanic women's breast and cervical cancer knowledge, attitudes, and screening behaviors.
    Ramirez AG; Suarez L; Laufman L; Barroso C; Chalela P
    Am J Health Promot; 2000; 14(5):292-300. PubMed ID: 11009855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imaging and informatics at the National Cancer Institute, part 1.
    Harrington DP
    J Am Coll Radiol; 2006 Feb; 3(2):88-9. PubMed ID: 17412016
    [No Abstract]   [Full Text] [Related]  

  • 55. National Institutes of Health/National Cancer Institute consensus development meeting on breast cancer screening: issues and recommendations.
    J Natl Cancer Inst; 1978 Jun; 60(6):1519-21. PubMed ID: 580621
    [No Abstract]   [Full Text] [Related]  

  • 56. Progress report on American Cancer Society/National Cancer Institute Breast Cancer Detection Demonstration Projects.
    Byrd BF
    Prog Clin Biol Res; 1977; 12():177-88. PubMed ID: 918097
    [No Abstract]   [Full Text] [Related]  

  • 57. Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures.
    Brown ML; Houn F; Sickles EA; Kessler LG
    AJR Am J Roentgenol; 1995 Dec; 165(6):1373-7. PubMed ID: 7484568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emerging technologies in breast cancer detection.
    Smith AP; Hall PA; Marcello DM
    Radiol Manage; 2004; 26(4):16-24; quiz 25-7. PubMed ID: 15377106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor receptor imaging: proceedings of the National Cancer Institute workshop, review of current work, and prospective for further investigations.
    Katzenellenbogen JA; Coleman RE; Hawkins RA; Krohn KA; Larson SM; Mendelsohn J; Osborne CK; Piwnica-Worms D; Reba RC; Siegel BA
    Clin Cancer Res; 1995 Aug; 1(8):921-32. PubMed ID: 9816063
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.